Cite
HARVARD Citation
Safadi, R. et al. (2021). Randomised clinical trial: A phase 2 double‐blind study of namodenoson in non‐alcoholic fatty liver disease and steatohepatitis. Alimentary pharmacology & therapeutics. 54 (11), pp. 1405-1415. [Online].